Patients who stopped taking fat-soluble statins had a 58% greater risk of developing Parkinson's disease than those who continued taking the cholesterol-lowering drugs, according to a study of almost 44,000 people. The rate of Parkinson's disease was about double among patients who took water-soluble statins compared with those treated with fat-soluble statins. The findings appear in the journal Neurology.

Full Story:
HealthDay News

Related Summaries